{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:19:01Z","timestamp":1782253141167,"version":"3.54.5"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/fpc.0b013e32832f3010","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T07:35:58Z","timestamp":1248852958000},"page":"613-625","source":"Crossref","is-referenced-by-count":56,"title":["Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes"],"prefix":"10.1097","volume":"19","author":[{"given":"Penelope A.","family":"Bradbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Kulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca S.","family":"Heist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Hooshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi","family":"Asomaning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances A.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Wain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Christiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210212","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L","article-title":"Demographic variations in the rising incidence of esophageal adenocarcinoma in white males","volume":"92","author":"Bollschweiler","year":"2001","journal-title":"Cancer"},{"key":"R2-5-20210212","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ejso.2004.06.008","article-title":"Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial","volume":"30","author":"Brucher","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"R3-5-20210212","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"Enzinger","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-5-20210212","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.surg.2004.06.033","article-title":"Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis","volume":"137","author":"Greer","year":"2005","journal-title":"Surgery"},{"key":"R5-5-20210212","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"R6-5-20210212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","article-title":"ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy","volume":"16","author":"Metzger","year":"1998","journal-title":"J Clin Oncol"},{"key":"R7-5-20210212","doi-asserted-by":"crossref","first-page":"23465","DOI":"10.1074\/jbc.272.38.23465","article-title":"Nucleotide excision repair in mammalian cells","volume":"272","author":"Wood","year":"1997","journal-title":"J Biol Chem"},{"key":"R8-5-20210212","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-2952(00)00441-X","article-title":"Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF","volume":"60","author":"Ferry","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"R9-5-20210212","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"R10-5-20210212","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/carcin\/21.5.965","article-title":"Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells","volume":"21","author":"Duell","year":"2000","journal-title":"Carcinogenesis"},{"key":"R11-5-20210212","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"R12-5-20210212","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"R13-5-20210212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","article-title":"XPD polymorphisms: effects on DNA repair proficiency","volume":"21","author":"Lunn","year":"2000","journal-title":"Carcinogenesis"},{"key":"R14-5-20210212","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","article-title":"Single nucleotide polymorphisms of the DNA repair gene XPD\/ERCC2 alter mRNA expression","volume":"17","author":"Wolfe","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"R15-5-20210212","first-page":"843","article-title":"Association of an ERCC1 polymorphism with adult-onset glioma","volume":"9","author":"Chen","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R16-5-20210212","first-page":"555","article-title":"Comparison of two human ovarian carcinoma cell lines 9A2780\/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene","volume":"16","author":"Yu","year":"2000","journal-title":"Int J Oncol"},{"key":"R17-5-20210212","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"R18-5-20210212","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","article-title":"Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer","volume":"15","author":"Isla","year":"2004","journal-title":"Ann Oncol"},{"key":"R19-5-20210212","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","article-title":"Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"10","author":"Zhou","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R20-5-20210212","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","article-title":"A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer","volume":"91","author":"Stoehlmacher","year":"2004","journal-title":"Br J Cancer"},{"key":"R21-5-20210212","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2006.05.8768","article-title":"DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy","volume":"24","author":"Quintela-Fandino","year":"2006","journal-title":"J Clin Oncol"},{"key":"R22-5-20210212","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1200\/JCO.2005.03.6640","article-title":"Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer","volume":"24","author":"Wu","year":"2006","journal-title":"J Clin Oncol"},{"key":"R23-5-20210212","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1200\/JCO.2006.10.4752","article-title":"Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer","volume":"25","author":"Marsh","year":"2007","journal-title":"J Clin Oncol"},{"key":"R24-5-20210212","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.bjc.6604671","article-title":"Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin\/5-fluorouracil as first line chemotherapy","volume":"99","author":"Par\u00e9","year":"2008","journal-title":"Br J Cancer"},{"key":"R25-5-20210212","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R26-5-20210212","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1158\/1055-9965.EPI-07-0470","article-title":"A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies","volume":"17","author":"Bradbury","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R27-5-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data","volume":"68","author":"Stephens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R28-5-20210212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000057986","article-title":"Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals","volume":"53","author":"Zaykin","year":"2002","journal-title":"Hum Hered"},{"key":"R29-5-20210212","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/gepi.20142","article-title":"Estimation and testing of genotype and haplotype effects in case-control studies: comparison of weighted regression and multiple imputation procedures","volume":"30","author":"Cordell","year":"2006","journal-title":"Genet Epidemiol"},{"key":"R30-5-20210212","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/B:BEGE.0000013734.39266.a3","article-title":"Haplotype association analysis of discrete and continuous traits using mixture of regression models","volume":"34","author":"Sham","year":"2004","journal-title":"Behav Genet"},{"key":"R31-5-20210212","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-07-4848","article-title":"Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy","volume":"14","author":"Kim","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R32-5-20210212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/JTO.0b013e318031cd89","article-title":"A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer","volume":"2","author":"Petty","year":"2007","journal-title":"J Thorac Oncol"},{"key":"R33-5-20210212","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1078-0432.CCR-04-1953","article-title":"Polymorphisms in ERCC1 and grade 3 and 4 toxicity in non-small cell lung cancer patients","volume":"11","author":"Suk","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R34-5-20210212","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0360-3016(95)00202-A","article-title":"Irradiation enhances cellular uptake of carboplatin","volume":"33","author":"Yang","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R35-5-20210212","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2217\/14622416.7.6.843","article-title":"Relationship between genetic polymorphisms and anticancer drug cytotoxicity vis-a-vis the NCI-60 panel","volume":"7","author":"Le Morvan","year":"2006","journal-title":"Pharmacogenomics"},{"key":"R36-5-20210212","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/carcin\/bgm020","article-title":"XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk","volume":"28","author":"Liu","year":"2007","journal-title":"Carcinogenesis"},{"key":"R37-5-20210212","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10552-008-9171-4","article-title":"Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk","volume":"19","author":"Tse","year":"2008","journal-title":"Cancer Causes Control"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0b013e32832f3010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:26:17Z","timestamp":1620951977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200908000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e32832f3010","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}